XML 48 R33.htm IDEA: XBRL DOCUMENT

Cash and Marketable Securities (Tables)

12 Months Ended

Dec. 31, 2024

Cash and Cash Equivalents [Abstract]

A reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the amount reported within the consolidated statements of cash flows is shown in the table below (in thousands):


	December 31, 2024		December 31, 2023		December 31, 2022
Cash and cash equivalents	$	114,689	$	82,197	$	89,921
Restricted cash	585		586		522
Total cash, cash equivalents, and restricted cash at the end of the period	$	115,274	$	82,783	$	90,443

Summary of Marketable Securities

The amortized cost, unrealized holding gains, and fair value of the Company’s marketable securities by major security type at each balance sheet date are summarized in the tables below (in thousands):


	December 31, 2024
	Amortized Cost		Unrealized Holding Gains		Fair Value
Short-term marketable securities:
U.S. agency securities	$	90,918	$	1,648	$	92,566
Corporate debt securities	55,046		718		55,764
Total short-term marketable securities	$	145,964	$	2,366	$	148,330


	December 31, 2023
	Amortized Cost		Unrealized Holding Gains		Fair Value
Short-term marketable securities:
U.S. agency securities	$	80,468	$	2,038	$	82,506
Corporate debt securities	72,753		711		73,464
Total short-term marketable securities	$	153,221	$	2,749	$	155,970